Table:
begin	end	state
1	5	non-cytoplasmic
6	26	transmembrane
27	40	cytoplasmic
41	62	transmembrane
63	67	non-cytoplasmic
68	70	transmembrane
71	75	non-cytoplasmic
76	93	transmembrane
94	123	cytoplasmic
124	151	transmembrane
152	162	non-cytoplasmic
163	184	transmembrane
185	192	cytoplasmic
193	213	transmembrane
214	232	non-cytoplasmic
233	254	transmembrane
255	275	cytoplasmic
276	297	transmembrane
298	324	non-cytoplasmic
325	349	transmembrane
350	370	cytoplasmic
371	391	transmembrane
392	402	non-cytoplasmic
403	422	transmembrane
423	428	cytoplasmic
429	447	transmembrane
448	452	non-cytoplasmic
453	473	transmembrane
474	494	cytoplasmic

Input:
>AO353_12815
MSASNPTLITFVIYIAAMVLIGFMAYRSTNNLSDYILGGRSLGSVVTALSAGASDMSGWL
LMGLPGAIYMSGLSESWIAIGLIVGAYLNWLFVAGRLRVQTEHNGDALTLPDYFSSRFED
KSGLLRIISAVVILVFFTIYCASGIVAGARLFESTFGMSYETALWAGAAATIAYTFVGGF
LAVSWTDTVQATLMIFALLLTPIIVLLATGGIDTTFLAIEAQDPGNFDMLKNTSFIGIIS
LMGWGLGYFGQPHILARFMAADSVKSIANARRISMTWMILCLGGTVAVGFFGIAYFSANP
AVAMPVSENHERVFIELAKILFNPWIAGVLLSAILAAVMSTLSCQLLVCSSALTEDFYKS
FLRKNASQVELVWVGRAMVLAVALIAIALAANPENRVLGLVSYAWAGFGAAFGPVVLISV
LWKGMTRNGALAGIVVGALTVIVWKHFNLLGLYEIIPGFIFASLAILLVSKMGVPSAGML
QRFAAAEKDFHLNK

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server